Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Gilead Sciences

www.gilead.com

333 Lakeside Drive
Foster City
California
CA 94404
United States

+1 650 574 3000

Activities

Research & Development | Pharmaceutical

Related Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

Hookipa and Gilead amend HIV immunotherapy agreement
Hookipa and Gilead amend HIV immunotherapy agreement
Gilead acquires Immunomedics for $21bn
Gilead acquires Immunomedics for $21bn
Cipla signs COVID-19 licensing agreement with Gilead Sciences
Cipla signs COVID-19 licensing agreement with Gilead Sciences
Hookipa Gilead collaboration reaches major milestones
Hookipa Gilead collaboration reaches major milestones
GlobalData publishes analysis of top 25 global pharma companies
GlobalData publishes analysis of top 25 global pharma companies
GlobalData names top 25 global pharma companies by market cap
GlobalData names top 25 global pharma companies by market cap
Selcia publishes strategy for structural simplification of natural products
Selcia publishes strategy for structural simplification of natural products
Genmab enters licensing agreement with Gilead for DuoBody technology
Genmab enters licensing agreement with Gilead for DuoBody technology
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Gilead and WuXi PharmaTech collaborate on analytical and stability testing project
Gilead and WuXi PharmaTech collaborate on analytical and stability testing project
North American pharmaceutical market focus shifting from prescriber to payer, says Globaldata
North American pharmaceutical market focus shifting from prescriber to payer, says Globaldata
US-India relations stall over pharma IP squabble
US-India relations stall over pharma IP squabble
Gilead opens innovative new laboratory
Gilead opens innovative new laboratory
Gilead Sciences to buy EpiTherapeutics for US$65m
Gilead Sciences to buy EpiTherapeutics for US$65m
New NCEs focus on cancer and orphan diseases
New NCEs focus on cancer and orphan diseases
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company